Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Five new Oxford-Bristol Myers Squibb Fellowships representing an investment of £3M have been announced. The fellowships (formerly Oxford-Celgene) will support postdoctoral researchers and clinicians across five departments within the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division, providing an opportunity for them to gain exposure to the field of commercial drug discovery and development.

Research scientists working in the laboratory

Women with chronic pelvic pain can be stratified using multimodal assessment.

Journal article

Demetriou L. et al, (2026), Pain, 167, 786 - 802

The autoantigen TRIM21 assembles proinflammatory immune complexes following lytic cell death

Journal article

Jones Evana EL. et al, (2026), Science immunology

Mechanistic impasses: tofacitinib treatment ameliorates GM-CSF-driven macrophage inflammation

Journal article

Clanchy FIL., (2026), Cellular & Molecular Immunology

Paradoxical Expression of Ionotropic Glutamate Receptors in Leucocytes.

Journal article

Clanchy FIL. et al, (2026), Clin Rev Allergy Immunol, 69

The epidemiology of cubital tunnel syndrome: a UK Biobank case-control study.

Journal article

Lucey M. et al, (2026), J Hand Surg Eur Vol

Progress towards drug treatment for melorheostosis.

Journal article

Wordsworth BP., (2026), J Bone Miner Res

Checkpoint blockade amplifies pro-regenerative type 2 immunity in tissue repair.

Journal article

Romero Arocha S. and Clarke A., (2026), Nat Rev Immunol

Load More